HomeCompareOCPNY vs BTI

OCPNY vs BTI: Dividend Comparison 2026

OCPNY yields 6.78% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCPNY wins by $36894.74M in total portfolio value
10 years
OCPNY
OCPNY
● Live price
6.78%
Share price
$18.00
Annual div
$1.22
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36894.78M
Annual income
$35,878,815,378.93
Full OCPNY calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — OCPNY vs BTI

📍 OCPNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCPNYBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCPNY + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCPNY pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCPNY
Annual income on $10K today (after 15% tax)
$576.66/yr
After 10yr DRIP, annual income (after tax)
$30,496,993,072.09/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, OCPNY beats the other by $30,496,990,703.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCPNY + BTI for your $10,000?

OCPNY: 50%BTI: 50%
100% BTI50/50100% OCPNY
Portfolio after 10yr
$18447.41M
Annual income
$17,939,409,082.79/yr
Blended yield
97.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

OCPNY
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCPNY buys
0
BTI buys
0
No recent congressional trades found for OCPNY or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCPNYBTI
Forward yield6.78%5.38%
Annual dividend / share$1.22$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%11.3%
Portfolio after 10y$36894.78M$37.7K
Annual income after 10y$35,878,815,378.93$2,786.64
Total dividends collected$36824.86M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OCPNY vs BTI ($10,000, DRIP)

YearOCPNY PortfolioOCPNY Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$12,057$1,356.84$11,299$598.92+$758.00OCPNY
2$15,959$3,057.79$12,794$703.91+$3.2KOCPNY
3$24,641$7,565.10$14,518$829.07+$10.1KOCPNY
4$48,199$21,833.39$16,513$978.64+$31.7KOCPNY
5$131,400$79,827.21$18,827$1,157.84+$112.6KOCPNY
6$547,374$406,775.39$21,518$1,373.12+$525.9KOCPNY
7$3,752,986$3,167,296.52$24,657$1,632.46+$3.73MOCPNY
8$44,606,539$40,590,843.20$28,329$1,945.74+$44.58MOCPNY
9$949,499,111$901,770,114.43$32,637$2,325.33+$949.47MOCPNY
10$36,894,779,427$35,878,815,378.93$37,708$2,786.64+$36894.74MOCPNY

OCPNY vs BTI: Complete Analysis 2026

OCPNYStock

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Full OCPNY Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this OCPNY vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCPNY vs SCHDOCPNY vs JEPIOCPNY vs OOCPNY vs KOOCPNY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.